Geneoscopy Appoints Dr. Haytham Gareer as Chief Medical Officer
Seasoned medical affairs executive to advance company's diagnostics product pipeline ST. LOUIS, Mo., Oct. 18, 2021 /PRNewswire/ -- Geneoscopy…
Geneoscopy Honored by Goldman Sachs for Entrepreneurship
Andrew Barnell, CEO, Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit ST. LOUIS, Oct. 13, 2021 /PRNewswire/ –…
Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial
Clinical Trial Investigates Company's Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention ST. LOUIS, July 12, 2021…
Geneoscopy Announces Publication of Peer-Reviewed Article Highlighting Effective Noninvasive Screening Test for Colorectal Cancer Prevention
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy Inc. today announced publication of the peer-reviewed article, “Multitarget Stool RNA Test for Noninvasive…
Geneoscopy Appoints Don Hardison to its Strategic Advisory Board
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the…
Geneoscopy Appoints Vince Wong as Chief Commercial Officer
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the…
Geneoscopy’s Preventive Screening Test for Colorectal Cancer and Precancerous Adenomas Earns FDA Breakthrough Device Designation
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI)…
Geneoscopy Raises $6.9 Million to Advance Preventive Screening Test for Colorectal Cancer and Advanced Adenomas
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI)…
